N-acetylcysteine protects against bupivacaine-induced myotoxicity caused by oxidative and sarcoplasmic reticulum stress in human skeletal myotubes

Anesthesiology

Volumn 113, Issue 3, 2010, Pages 560-569

  Galbes, Olivier ^a   Bourret, Annick ^b   Nouette Gaulain, Karine ^b,c,d   Pillard, Fabien ^e   Matecki, Stefan ^b,f   Py, Guillaume ^a   Mercier, Jacques ^b   Capdevila, Xavier ^b,g   Philips, Alexandre ^b,f  

^a University of Montpellier   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d HÔPITAL PELLEGRIN   (France)

^e SERVICE DE PNEUMOLOGIE   (France)

^f HÔPITAL ARNAUD DE VILLENEUVE   (France)

^g LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BUPIVACAINE; CASPASE 7; CASPASE 9; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; LOCAL ANESTHESIA; MUSCLE TOXICITY; MYOTUBE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE; TOXICITY; CELL CULTURE; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; BUPIVACAINE; CELLS, CULTURED; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SARCOPLASMIC RETICULUM;

EID: 77956986804     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181e4f4ec     Document Type: Article

References (33)

1. Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F: Effects of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. ANESTHESIOLOGY 1999; 91:8-15
2. Capdevila X, Pirat P, Bringuier S, Gaertner E, Singelyn F, Bernard N, Choquet O, Bouaziz H, Bonnet F, French Study Group on Continuous Peripheral Nerve Blocks: Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: A multicenter prospective analysis of the quality of postoperative analgesia and complications in 1,416 patients. ANESTHESIOLOGY 2005; 103:1035-1045
3. Richman JM, Liu SS, Courpas G, Wong R, Rowlingson AJ, McGready J, Cohen SR, Wu CL: Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis. Anesth Analg 2006; 102:248-257
4. Hogan Q, Dotson R, Erickson S, Kettler R, Hogan K: Local anesthetic myotoxicity: A case and review. ANESTHESIOLOGY 1994; 80:942-947
5. Nouette-Gaulain K, Sirvent P, Canal-Raffin M, Morau D, Malgat M, Molimard M, Mercier J, Lacampagne A, Sztark F, Capdevila X: Effects of intermittent femoral nerve injections of bupivacaine, levobupivacaine, and ropivacaine on mitochondrial energy metabolism and intracellular calcium homeostasis in rat psoas muscle. ANESTHESIOLOGY 2007; 106:1026-1034
6. Gómez-Arnau JI, Yangüela J, González A, Andrés Y, García del Valle S, Gili P, Fernández-Guisasola J, Arias A: Anaesthesia- related diplopia after cataract surgery. Br J Anaesth 2003; 90:189-193
7. Zink W, Graf BM: Local anesthetic myotoxicity. Reg Anesth Pain Med 2004; 29:333-340 (Pubitemid 39055660)
8. Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ: Mitochondrial injury and caspase activation by the local anesthetic lidocaine. ANESTHESIOLOGY 2004; 101:1184-1194
9. Werdehausen R, Braun S, Essmann F, Schulze-Osthoff K, Walczak H, Lipfert P, Stevens MF: Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling. ANESTHESIOLOGY 2007; 107:136-143
10. Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S, Reggiani C, Salviati G, Bernardi P: Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem 2002; 277:12221-12227
11. Sztark F, Nouette-Gaulain K, Malgat M, Dabadie P, Mazat JP: Absence of stereospecific effects of bupivacaine isomers on heart mitochondrial bioenergetics. ANESTHESIOLOGY 2000; 93:456-462
12. Benoit PW, Yagiela A, Fort NF: Pharmacologic correlation between local anesthetic-induced myotoxicity and disturbances of intracellular calcium distribution. Toxicol Appl Pharmacol 1980; 52:187-198
13. Zink W, Seif C, Bohl JR, Hacke N, Braun PM, Sinner B, Martin E, Fink RH, Graf BM: The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades. Anesth Analg 2003; 97:1173-1179
14. Komai H, Lokuta AJ: Interaction of bupivacaine and tetracaine with the sarcoplasmic reticulum Ca2+ release channel of skeletal and cardiac muscles. ANESTHESIOLOGY 1999; 90:835-843
15. Takahashi S: Local anaesthetic bupivacaine alters function of sarcoplasmic reticulum and sarcolemmal vesicles from rabbit masseter muscle. Pharmacol Toxicol 1994; 75:119-128
16. + regulation: Potential mechanisms of its myotoxicity. ANESTHESIOLOGY 2002; 97:710-716
17. Unami A, Shinohara Y, Ichikawa T, Baba Y: Biochemical and microarray analyses of bupivacaine-induced apoptosis. J Toxicol Sci 2003; 28:77-94
18. Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD: XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell 2007; 27:53-66
19. Kim I, Xu W, Reed JC: Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities. Nat Rev Drug Discov 2008; 7:1013-1030
20. Kitzmann M, Bonnieu A, Duret C, Vernus B, Barro M, Laoudj- Chenivesse D, Verdi JM, Carnac G: Inhibition of Notch signaling induces myotube hypertrophy by recruiting a subpopulation of reserve cells. J Cell Physiol 2006; 208:538-548
21. Coisy-Quivy M, Touzet O, Bourret A, Hipskind RA, Mercier J, Fort P, Philips A: TC10 controls human myofibril organization and is activated by the sarcomeric RhoGEF obscurin. J Cell Sci 2009; 122:947-956
22. Rao RV, Hermel E, Castro-Obregon S, del Rio G, Ellerby LM, Ellerby HM, Bredesen DE: Coupling endoplasmic reticulum stress to the cell death program: Mechanism of caspase activation. J Biol Chem 2001; 276:33869-33874
23. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D: CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004; 18:3066-3077
24. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M: Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 2002; 109:525-532
25. Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D: CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 1998; 12:982-995
26. Gotoh T, Mori M: Nitric oxide and endoplasmic reticulum stress. Arterioscler Thromb Vasc Biol 2006; 26:1439-1446
27. Nouette-Gaulain K, Bellance N, Prévost B, Passerieux E, Pertuiset C, Galbes O, Smolkova K, Masson F, Miraux S, Delage JP, Letellier T, Rossignol R, Capdevila X, Sztark F: Erythropoietin protects against local anesthetic myotoxicity during continuous regional analgesia. ANESTHESIOLOGY 2009; 110:648-659
28. Maemura Y: Effect of ropivacaine on Ca function of skinned skeletal muscle. Masui 2002; 51:19-24
29. +-ATPase in skeletal muscle. Biochem J 1999; 340:657-669
30. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC: Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 1999; 96:657-662
31. Xu L, Eu JP, Meissner G, Stamler JS: Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998; 279:234-237
32. Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, Kim HJ: Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res 2005; 84:852-857
33. Rosencher N, Poisson D, Albi A, Aperce M, Barré J, Samama CM: Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth 2005; 52:160-165